Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 935

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 935
---
 | ​ | 19,134,164 | ​ | ​ | ​ | ​      | $ | 19 | ​ | ​ | ​ | ​                        | $ | 677 | ​ | ​ | ​ | ​                  | $ | -58,488 | ​ | ​ | ​ | ​                                 | $ |   — | ​ | ​ | ​ | ​                         | $ | -57,792 | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-117

TABLE OF CONTENTS

Tvardi Therapeutics, Inc. CONDENSED Statements of Cash Flows
(Amounts in thousands)
(Unaudited)

| ​                                                                           
 ​                                                                           
 Cash flows from operating activities:                                       | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | For the Nine Months EndedSeptember 30, 
 2024                                   
 ​                                      | ​ |       ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2023 
 ​    | ​ |       ​ | ​ | ​ 
 ​ 
 ​ |
|:----------------------------------------------------------------------------|:--|:--|:---------------------------------------|:--|--------:|:--|:--|:--|:-----|:--|--------:|:--|:--|
| Net loss                                                                    | ​ | ​ | ​                                      | $ | -16,690 | ​ | ​ | ​ | ​    | $ | -12,996 | ​ | ​ |
| Adjustments to reconcile net loss to net cash used in operating activities: | ​ | ​ | ​                                      | ​ |       ​ | ​ | ​ | ​ | ​    | ​ |       ​ | ​ | ​ |
| Depreciation and amortization expense                                       | ​ | ​ | ​                                      | ​ |      71 | ​ | ​ | ​ | ​    | ​ |      71 | ​ | ​ |
| Stock-based compensation expense                                            | ​ | ​ | ​                                      | ​ |     240 | ​ | ​ | ​ | ​    | ​ |     229 | ​ | ​ |
| Non-cash lease expense                                                      | ​ | ​ | ​                                      | ​ |      44 | ​ | ​ | ​ | ​    | ​ |      38 | ​ | ​ |
| Accretion of discounts on short-term investments                            | ​ | ​ | ​                                      | ​ |       — | ​ | ​ | ​ | ​    | ​ |    -194 | ​ |